HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Sheng Selected Research

Atrial Natriuretic Factor (ANF)

12/2015Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
2/2008Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
10/2004[Study on relationship among thyroid hormone relativity and Syndrome Differentiation-types of TCM in patients with congestive heart failure].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Sheng Research Topics

Disease

35Neoplasms (Cancer)
04/2024 - 01/2005
14Atrial Fibrillation
05/2020 - 01/2007
13Fibrosis (Cirrhosis)
01/2024 - 01/2007
9Inflammation (Inflammations)
02/2024 - 01/2006
7Insulin Resistance
09/2023 - 01/2006
7Infections
11/2021 - 01/2006
6Tuberculosis (Tuberculoses)
11/2022 - 05/2014
5Hypertrophy
12/2017 - 12/2005
5Cardiomegaly (Heart Hypertrophy)
12/2015 - 12/2005
4Hypertension (High Blood Pressure)
03/2024 - 09/2005
4Hepatitis
01/2024 - 10/2009
4Liver Diseases (Liver Disease)
05/2023 - 07/2013
4Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
11/2022 - 05/2017
4Thrombosis (Thrombus)
02/2021 - 10/2014
4Carcinoma (Carcinomatosis)
10/2018 - 06/2005
3Peritoneal Fibrosis
04/2024 - 06/2023
3Non-alcoholic Fatty Liver Disease
05/2023 - 01/2021
3Multiple Myeloma
04/2022 - 06/2014
3Wounds and Injuries (Trauma)
02/2022 - 03/2014
3Heart Failure
01/2022 - 10/2004
3Atherosclerosis
01/2022 - 10/2018
3Body Weight (Weight, Body)
01/2021 - 01/2006
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2010
3Experimental Arthritis
05/2020 - 12/2017
3Neoplasm Metastasis (Metastasis)
10/2018 - 10/2017
2Chronic Kidney Failure (Chronic Renal Failure)
04/2024 - 01/2013
2Chemical and Drug Induced Liver Injury
04/2024 - 04/2017
2Hematologic Neoplasms (Hematological Malignancy)
04/2024 - 04/2022
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2024 - 01/2019
2Acute Kidney Injury (Acute Renal Failure)
08/2023 - 01/2017
2Carotid Artery Diseases
01/2022 - 01/2013
2Chronic Renal Insufficiency
01/2022 - 01/2013
2Edema (Dropsy)
01/2022 - 10/2004
2Breast Neoplasms (Breast Cancer)
11/2021 - 01/2016
2Cysts
11/2021 - 10/2020
2Echinococcosis (Hydatid Cysts)
11/2021 - 10/2020
2Hepatocellular Carcinoma (Hepatoma)
03/2021 - 04/2015
2COVID-19
01/2021 - 10/2020
2Retinal Degeneration
01/2021 - 07/2015
2Pituitary Neoplasms (Pituitary Adenoma)
01/2021 - 12/2018
2Virus Diseases (Viral Diseases)
01/2021 - 10/2020
2Diabetes Mellitus
01/2021 - 04/2013
2Leprosy (Hansen's Disease)
01/2021 - 10/2020
2Myocardial Infarction
02/2019 - 04/2007

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
03/2024 - 04/2006
9Messenger RNA (mRNA)IBA
03/2024 - 12/2005
6bicyclolIBA
04/2024 - 11/2008
6Glucose (Dextrose)FDA LinkGeneric
09/2023 - 01/2006
6Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2013
5LipidsIBA
07/2022 - 07/2009
5Angiotensin IIIBA
12/2015 - 12/2005
4DNA (Deoxyribonucleic Acid)IBA
05/2023 - 01/2006
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2022 - 02/2008
4Long Noncoding RNAIBA
12/2020 - 01/2017
4ResveratrolIBA
05/2020 - 06/2005
4Insulin (Novolin)FDA Link
11/2019 - 01/2006
4CalpainIBA
04/2008 - 02/2007
3Therapeutic UsesIBA
01/2024 - 11/2018
3Immunoglobulin G (IgG)IBA
01/2024 - 08/2017
3Interleukin-6 (Interleukin 6)IBA
09/2023 - 12/2017
3CytokinesIBA
09/2023 - 09/2005
3PPAR gammaIBA
12/2022 - 01/2006
3coumarinIBA
02/2022 - 01/2019
3Oxazolidinones (2 Oxazolidone)IBA
03/2021 - 05/2017
3Proteasome Endopeptidase Complex (Proteasome)IBA
02/2019 - 06/2014
3AutoantibodiesIBA
01/2019 - 07/2013
3AdiponectinIBA
11/2016 - 01/2006
3Atrial Natriuretic Factor (ANF)IBA
12/2015 - 10/2004
3Atorvastatin (Lipitor)FDA Link
12/2015 - 12/2005
3PPAR alphaIBA
10/2010 - 12/2005
3calpain inhibitorsIBA
10/2009 - 08/2007
2IMM-H004IBA
02/2024 - 01/2019
2benzamideIBA
11/2023 - 12/2022
2CoumarinsIBA
11/2023 - 01/2017
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2023 - 07/2018
2p38 Mitogen-Activated Protein KinasesIBA
08/2023 - 01/2012
2LipopolysaccharidesIBA
05/2023 - 01/2017
2ColchicineFDA LinkGeneric
12/2022 - 12/2020
2TubulinIBA
12/2022 - 12/2020
2Bortezomib (Velcade)FDA Link
04/2022 - 06/2014
2AntioxidantsIBA
01/2022 - 01/2017
2CollagenIBA
11/2021 - 01/2019
2N-dodecyl-L-lysine amideIBA
11/2021 - 11/2013
2Rifampin (Rifampicin)FDA LinkGeneric
11/2021 - 12/2015
2Albendazole (Albenza)FDA Link
11/2021 - 10/2020
2oxidized low density lipoproteinIBA
01/2021 - 11/2019
2remdesivirIBA
01/2021 - 10/2020
2Clofazimine (Lamprene)FDA Link
01/2021 - 10/2020
2Paclitaxel (Taxol)FDA LinkGeneric
12/2020 - 10/2018
2MicroRNAs (MicroRNA)IBA
12/2020 - 01/2014
2EnzymesIBA
03/2020 - 07/2006
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
03/2020 - 06/2019
2Blood Glucose (Blood Sugar)IBA
11/2019 - 08/2010
2HDL CholesterolIBA
11/2019 - 01/2013
2Proteasome InhibitorsIBA
02/2019 - 12/2016
24-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2019 - 12/2010

Therapy/Procedure

17Therapeutics
01/2024 - 01/2005
4Catheters
10/2021 - 10/2014
3Drug Therapy (Chemotherapy)
04/2024 - 10/2018
3Oral Administration
04/2022 - 06/2019